work with
Working With Genzyme
Print Text Size
We work with many outside companies and individuals throughout the science, medical, and biotechnology communities, who help contribute to Genzyme's mission of making a major positive impact on patients worldwide.

No company succeeds entirely on its own. In the complex, ever-evolving field of biotechnology, Genzyme relies on strong business relationships to help us advance important medical breakthroughs. We work with a wide variety of talented individuals and organizations, from academic researchers and innovative entrepreneurs to those who provide the critical supplies that our manufacturing operations require.

If you're interested in working with one of the world's leading biotech companies, explore the opportunities outlined below.

Other Opportunities

Partnering Collaboration is a core value at Genzyme, where our employees work closely across disciplines to share expertise. That spirit of teamwork also drives our external partnerships, as we seek complementary strengths to help us bring effective products to the people who need them most. More
Sanofi-Genzyme BioVentures A $100 million strategic corporate venture capital fund, Sanofi-Genzyme BioVentures invests in early-stage innovative life science companies that demonstrate promise to deliver breakthrough products that may be future Sanofi pipeline candidates. More
Manufacturing Suppliers With numerous laboratories and manufacturing facilities around the world, Genzyme relies on the industry's top suppliers of materials and equipment to help bring our innovative products to market. More
Back to top
Contact Us
Genzyme Partnering

49 New York Avenue
Framingham, MA 01701
USA

Send email

EU Partnering

Gooimeer 10
1411 DD NAARDEN
The Netherlands
F: +31 35 699 1400

Send email
Humanitarian Partners

Our free drug programs and other humanitarian efforts are made possible with the help of these and other partners:

Research Collaboration in Parkinson’s

Genzyme, the Michael J. Fox Foundation, and the University of California San Francisco have joined forces to study a gene therapy approach to treat Parkinson’s disease. Read an interview with Rich Gregory, Head of the Sanofi-Genzyme R&D Center, to find out about this innovative partnership between academia and industry.

Related Information
Also on Genzyme.com
infoBox